Hexavalent vaccines: increasing options for policy-makers and providers. A review of the data supporting interchangeability (substitution with vaccines containing fewer antigens) and mixed schedules from the same manufacturer

Jan Dolhain, Winnie Janssens, Narcisa Mesaros, Linda Hanssens, Frederik Fierens
  • Expert Review of Vaccines, June 2018, Taylor & Francis
  • DOI: 10.1080/14760584.2018.1419070
The author haven't yet claimed this publicationThe author haven't yet claimed this publication
Read Publication

http://dx.doi.org/10.1080/14760584.2018.1419070

In partnership with: